COLUMBIA, Md., Jan. 27, 2022 /PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases, has announced the launch of the Diana Davis Spencer Foundation Enhanced Translational Research Acceleration Program. This Program is designed to accelerate the progress of particularly promising preclinical research toward an Investigational New Drug filing that can lead to follow-on investment and clinical trials — providing a robust and diverse pipeline of potential therapies to fight inherited retinal degenerative diseases.

"We are honored by the Diana Davis Spencer Foundation's relentless commitment to supporting the mission of the Foundation Fighting Blindness to find treatments and cures for inherited retinal diseases," said Benjamin Yerxa, PhD, chief executive officer, Foundation Fighting Blindness. "This level of investment drives the acceleration of the very best researchers in the retinal field."

More on Marylandian

• Coming Up this Weekend on CNBC Mike Milligan Joins Tom Hegna on "Financial Freedom with Tom Hegna"
• Parker Stone Unleashes the Highly Anticipated Dark Romance, "The Reluctant Heir," Out Today
• UK Website Launches "Toy Time Machine" — Find Your Childhood Christmas Toy in One Click
• $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
• Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"

In addition, the Foundation Fighting Blindness will develop the Diana Davis Spencer Foundation Career Development Award to provide financial support and protected time to conduct clinical research to individuals with MD or MD/PhD degrees. This contribution will facilitate advances in laboratory and clinical research and ultimately lead to a clinical research career in the field of retinal diseases. Research projects and clinical training activities will focus on inherited retinal degenerative diseases.

"We're thrilled to continue our longstanding support for the Foundation Fighting Blindness," said Abby Moffat, president and CEO of the Diana Davis Spencer Foundation. "We are proud of their half-century commitment as leaders in retinal research and look forward to the day these diseases are eradicated."

About the Foundation Fighting Blindness
Established in 1971, the Foundation Fighting Blindness is the world's leading private funding source for retinal degenerative disease research. The Foundation has raised more than $856 million toward its mission of accelerating research for preventing, treating, and curing blindness caused by the entire spectrum of blinding retinal diseases including: retinitis pigmentosa, macular degeneration, and Usher syndrome. Visit FightingBlindness.org for more information.

More on Marylandian

• Thread Advisory Group Launches to Help Retailers Turn Strategy Into Lasting Results
• QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
• New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
• CRG Named One of OrangeSlices' 2026 Elev8 GovCon Honorees
• Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications

About the Diana Davis Spencer Foundation
The Diana Davis Spencer Foundation espouses the values upon which our nation was founded: freedom and individual responsibility. The mission of the foundation is to promote national security, entrepreneurship, self-reliance, free enterprise, and to enhance quality of life by supporting the arts, education, global understanding, health advancements, and preservation of the environment. Visit DDSFoundation.org.

Media Contact:
Chris Adams
Vice President, Marketing & Communications
[email protected]
410-423-0585

SOURCE Foundation Fighting Blindness

---

Show All News | Report Violation